APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radiopharmaceuticals for Diagnosis

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Radiopharmaceuticals for Diagnosis Market Outlook and Growth Opportunities 2026

27 December 2025202 pages

Choose your research edition.

Industry ResearchRadiopharmaceuticals for Diagnosis Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiopharmaceuticals for Diagnosis Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Radiopharmaceuticals for Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiopharmaceuticals for Diagnosis Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiopharmaceuticals for Diagnosis Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Radiopharmaceuticals for Diagnosis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Radiopharmaceuticals for Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Radiopharmaceuticals for Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Radiopharmaceuticals for Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Radiopharmaceuticals for Diagnosis market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Radiopharmaceuticals for Diagnosis market include Atom High-tech Co., Ltd., Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory, Tianjin Said Biopharmaceutical Co., Ltd., Shenzhen Larven Bioengineering Technology Co., Ltd., Shanghai Atom Kexing Pharmaceutical Co., Ltd., Shanghai Xinke Pharmaceutical Co., Ltd., Ningbo Jun'an Pharmaceutical Technology Co., Ltd., Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. and Guangdong Xi'ai Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Radiopharmaceuticals for Diagnosis market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Radiopharmaceuticals for Diagnosis and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Radiopharmaceuticals for Diagnosis sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Radiopharmaceuticals for Diagnosis market size, projected growth trends, production technologies, key applications, and end-use industries.

Radiopharmaceuticals for Diagnosis Segment by Company

Atom High-tech Co., Ltd.

Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory

Tianjin Said Biopharmaceutical Co., Ltd.

Shenzhen Larven Bioengineering Technology Co., Ltd.

Shanghai Atom Kexing Pharmaceutical Co., Ltd.

Shanghai Xinke Pharmaceutical Co., Ltd.

Ningbo Jun'an Pharmaceutical Technology Co., Ltd.

Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.

Guangdong Xi'ai Pharmaceutical Co., Ltd.

Chengdu Zhonghe Gaotong Isotope Co., Ltd.

Chengdu Yunke Pharmaceutical Co., Ltd.

Chengdu Xinke Pharmaceutical Co., Ltd.

Beijing Zhibo High-tech Biotechnology Co., Ltd.

RadioMedix, Inc.

PDRadiopharma Inc.

Lantheus

Jubilant Radiopharma

GE Healthcare Ltd

DOE IP

Radiopharmaceuticals for Diagnosis Segment by Type

Strontium [89Sr] Chloride

Sodium Iodide [131I]

Iodine [125I] Sealed Seed Source

Technetium [99mTc] Pentetate

Technetium [99mTc] Polymerized Albumin

Technetium [99mTc] Dithiodithiocarbamate

Other

Radiopharmaceuticals for Diagnosis Segment by Application

Hospital

Clinic

Other

Radiopharmaceuticals for Diagnosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Radiopharmaceuticals for Diagnosis status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Radiopharmaceuticals for Diagnosis market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Radiopharmaceuticals for Diagnosis significant trends, drivers, influence factors in global and regions.

6. To analyze Radiopharmaceuticals for Diagnosis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceuticals for Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceuticals for Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceuticals for Diagnosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Radiopharmaceuticals for Diagnosis market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Radiopharmaceuticals for Diagnosis industry.

Chapter 3: Detailed analysis of Radiopharmaceuticals for Diagnosis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Radiopharmaceuticals for Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Radiopharmaceuticals for Diagnosis in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Radiopharmaceuticals for Diagnosis Industry Trends Table 2. Radiopharmaceuticals for Diagnosis Industry Drivers Table 3. Radiopharmaceuticals for Diagnosis Industry Opportunities and Challenges Table 4. Radiopharmaceuticals for Diagnosis Industry Restraints Table 5. Global Radiopharmaceuticals for Diagnosis Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Radiopharmaceuticals for Diagnosis Revenue Share by Company (2021-2026) Table 7. Global Radiopharmaceuticals for Diagnosis Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Radiopharmaceuticals for Diagnosis Sales Volume Share by Company (2021-2026) Table 9. Global Radiopharmaceuticals for Diagnosis Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Radiopharmaceuticals for Diagnosis Company Ranking, (2024-2026) & (USD Million) Table 11. Global Radiopharmaceuticals for Diagnosis Key Company Manufacturing Base & Headquarters Table 12. Global Radiopharmaceuticals for Diagnosis Company, Product Type & Application Table 13. Global Radiopharmaceuticals for Diagnosis Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Radiopharmaceuticals for Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Strontium [89Sr] Chloride Table 18. Significant Companies of Sodium Iodide [131I] Table 19. Significant Companies of Iodine [125I] Sealed Seed Source Table 20. Significant Companies of Technetium [99mTc] Pentetate Table 21. Significant Companies of Technetium [99mTc] Polymerized Albumin Table 22. Significant Companies of Technetium [99mTc] Dithiodithiocarbamate Table 23. Significant Companies of Other Table 24. Global Radiopharmaceuticals for Diagnosis Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Radiopharmaceuticals for Diagnosis Sales Volume by Type (2021-2026) & (K Units) Table 26. Global Radiopharmaceuticals for Diagnosis Sales Volume by Type (2027-2032) & (K Units) Table 27. Global Radiopharmaceuticals for Diagnosis Sales Volume Share by Type (2021-2026) Table 28. Global Radiopharmaceuticals for Diagnosis Sales Volume Share by Type (2027-2032) Table 29. Global Radiopharmaceuticals for Diagnosis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Radiopharmaceuticals for Diagnosis Sales Value by Type (2021-2026) & (US$ Million) Table 31. Global Radiopharmaceuticals for Diagnosis Sales Value by Type (2027-2032) & (US$ Million) Table 32. Global Radiopharmaceuticals for Diagnosis Sales Value Share by Type (2021-2026) Table 33. Global Radiopharmaceuticals for Diagnosis Sales Value Share by Type (2027-2032) Table 34. Significant Companies of Hospital Table 35. Significant Companies of Clinic Table 36. Significant Companies of Other Table 37. Global Radiopharmaceuticals for Diagnosis Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Radiopharmaceuticals for Diagnosis Sales Volume by Application (2021-2026) & (K Units) Table 39. Global Radiopharmaceuticals for Diagnosis Sales Volume by Application (2027-2032) & (K Units) Table 40. Global Radiopharmaceuticals for Diagnosis Sales Volume Share by Application (2021-2026) Table 41. Global Radiopharmaceuticals for Diagnosis Sales Volume Share by Application (2027-2032) Table 42. Global Radiopharmaceuticals for Diagnosis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Radiopharmaceuticals for Diagnosis Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Radiopharmaceuticals for Diagnosis Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Radiopharmaceuticals for Diagnosis Sales Value Share by Application (2021-2026) Table 46. Global Radiopharmaceuticals for Diagnosis Sales Value Share by Application (2027-2032) Table 47. Global Radiopharmaceuticals for Diagnosis Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 48. Global Radiopharmaceuticals for Diagnosis Sales by Region (2021-2026) & (K Units) Table 49. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Region (2021-2026) Table 50. Global Radiopharmaceuticals for Diagnosis Sales by Region (2027-2032) & (K Units) Table 51. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Region (2027-2032) Table 52. Global Radiopharmaceuticals for Diagnosis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Radiopharmaceuticals for Diagnosis Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Radiopharmaceuticals for Diagnosis Sales Value Share by Region (2021-2026) Table 55. Global Radiopharmaceuticals for Diagnosis Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Radiopharmaceuticals for Diagnosis Sales Value Share by Region (2027-2032) Table 57. Global Radiopharmaceuticals for Diagnosis Market Average Price (US$/Unit) by Region (2021-2026) Table 58. Global Radiopharmaceuticals for Diagnosis Market Average Price (US$/Unit) by Region (2027-2032) Table 59. Global Radiopharmaceuticals for Diagnosis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Global Radiopharmaceuticals for Diagnosis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units) Table 62. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2021-2026) Table 63. Global Radiopharmaceuticals for Diagnosis Sales by Country (2027-2032) & (K Units) Table 64. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2027-2032) Table 65. Global Radiopharmaceuticals for Diagnosis Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Radiopharmaceuticals for Diagnosis Sales Value Market Share by Country (2021-2026) Table 67. Global Radiopharmaceuticals for Diagnosis Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Radiopharmaceuticals for Diagnosis Sales Value Market Share by Country (2027-2032) Table 69. Atom High-tech Co., Ltd. Company Information Table 70. Atom High-tech Co., Ltd. Business Overview Table 71. Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 73. Atom High-tech Co., Ltd. Recent Development Table 74. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Company Information Table 75. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Business Overview Table 76. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Portfolio Table 78. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Recent Development Table 79. Tianjin Said Biopharmaceutical Co., Ltd. Company Information Table 80. Tianjin Said Biopharmaceutical Co., Ltd. Business Overview Table 81. Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 83. Tianjin Said Biopharmaceutical Co., Ltd. Recent Development Table 84. Shenzhen Larven Bioengineering Technology Co., Ltd. Company Information Table 85. Shenzhen Larven Bioengineering Technology Co., Ltd. Business Overview Table 86. Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 88. Shenzhen Larven Bioengineering Technology Co., Ltd. Recent Development Table 89. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Company Information Table 90. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Business Overview Table 91. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 93. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Recent Development Table 94. Shanghai Xinke Pharmaceutical Co., Ltd. Company Information Table 95. Shanghai Xinke Pharmaceutical Co., Ltd. Business Overview Table 96. Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 98. Shanghai Xinke Pharmaceutical Co., Ltd. Recent Development Table 99. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Company Information Table 100. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Business Overview Table 101. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 103. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Recent Development Table 104. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Company Information Table 105. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Business Overview Table 106. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 108. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Recent Development Table 109. Guangdong Xi'ai Pharmaceutical Co., Ltd. Company Information Table 110. Guangdong Xi'ai Pharmaceutical Co., Ltd. Business Overview Table 111. Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 113. Guangdong Xi'ai Pharmaceutical Co., Ltd. Recent Development Table 114. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Company Information Table 115. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Business Overview Table 116. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 118. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Recent Development Table 119. Chengdu Yunke Pharmaceutical Co., Ltd. Company Information Table 120. Chengdu Yunke Pharmaceutical Co., Ltd. Business Overview Table 121. Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 123. Chengdu Yunke Pharmaceutical Co., Ltd. Recent Development Table 124. Chengdu Xinke Pharmaceutical Co., Ltd. Company Information Table 125. Chengdu Xinke Pharmaceutical Co., Ltd. Business Overview Table 126. Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 128. Chengdu Xinke Pharmaceutical Co., Ltd. Recent Development Table 129. Beijing Zhibo High-tech Biotechnology Co., Ltd. Company Information Table 130. Beijing Zhibo High-tech Biotechnology Co., Ltd. Business Overview Table 131. Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 133. Beijing Zhibo High-tech Biotechnology Co., Ltd. Recent Development Table 134. RadioMedix, Inc. Company Information Table 135. RadioMedix, Inc. Business Overview Table 136. RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product Portfolio Table 138. RadioMedix, Inc. Recent Development Table 139. PDRadiopharma Inc. Company Information Table 140. PDRadiopharma Inc. Business Overview Table 141. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Portfolio Table 143. PDRadiopharma Inc. Recent Development Table 144. Lantheus Company Information Table 145. Lantheus Business Overview Table 146. Lantheus Radiopharmaceuticals for Diagnosis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Lantheus Radiopharmaceuticals for Diagnosis Product Portfolio Table 148. Lantheus Recent Development Table 149. Jubilant Radiopharma Company Information Table 150. Jubilant Radiopharma Business Overview Table 151. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Portfolio Table 153. Jubilant Radiopharma Recent Development Table 154. GE Healthcare Ltd Company Information Table 155. GE Healthcare Ltd Business Overview Table 156. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Portfolio Table 158. GE Healthcare Ltd Recent Development Table 159. DOE IP Company Information Table 160. DOE IP Business Overview Table 161. DOE IP Radiopharmaceuticals for Diagnosis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. DOE IP Radiopharmaceuticals for Diagnosis Product Portfolio Table 163. DOE IP Recent Development Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Radiopharmaceuticals for Diagnosis Distributors List Table 167. Radiopharmaceuticals for Diagnosis Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Radiopharmaceuticals for Diagnosis Product Image Figure 2. Global Radiopharmaceuticals for Diagnosis Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiopharmaceuticals for Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 4. Global Radiopharmaceuticals for Diagnosis Sales (2021-2032) & (K Units) Figure 5. Global Radiopharmaceuticals for Diagnosis Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Radiopharmaceuticals for Diagnosis Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Strontium [89Sr] Chloride Image Figure 10. Sodium Iodide [131I] Image Figure 11. Iodine [125I] Sealed Seed Source Image Figure 12. Technetium [99mTc] Pentetate Image Figure 13. Technetium [99mTc] Polymerized Albumin Image Figure 14. Technetium [99mTc] Dithiodithiocarbamate Image Figure 15. Other Image Figure 16. Global Radiopharmaceuticals for Diagnosis Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Radiopharmaceuticals for Diagnosis Sales Volume Share 2021 VS 2025 VS 2032 Figure 18. Global Radiopharmaceuticals for Diagnosis Sales Volume Share by Type (2021-2032) Figure 19. Global Radiopharmaceuticals for Diagnosis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Radiopharmaceuticals for Diagnosis Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Radiopharmaceuticals for Diagnosis Sales Value Share by Type (2021-2032) Figure 22. Hospital Image Figure 23. Clinic Image Figure 24. Other Image Figure 25. Global Radiopharmaceuticals for Diagnosis Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Radiopharmaceuticals for Diagnosis Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Radiopharmaceuticals for Diagnosis Sales Volume Share by Application (2021-2032) Figure 28. Global Radiopharmaceuticals for Diagnosis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Radiopharmaceuticals for Diagnosis Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Radiopharmaceuticals for Diagnosis Sales Value Share by Application (2021-2032) Figure 31. Global Radiopharmaceuticals for Diagnosis Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 32. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Radiopharmaceuticals for Diagnosis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Radiopharmaceuticals for Diagnosis Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Radiopharmaceuticals for Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 36. North America Radiopharmaceuticals for Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Radiopharmaceuticals for Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Radiopharmaceuticals for Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Radiopharmaceuticals for Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 42. South America Radiopharmaceuticals for Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Radiopharmaceuticals for Diagnosis Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Radiopharmaceuticals for Diagnosis Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • Strontium [89Sr] Chloride
  • Sodium Iodide [131I]
  • Iodine [125I] Sealed Seed Source
  • Technetium [99mTc] Pentetate
  • Technetium [99mTc] Polymerized Albumin
  • Technetium [99mTc] Dithiodithiocarbamate
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Atom High-tech Co., Ltd.
  • Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
  • Tianjin Said Biopharmaceutical Co., Ltd.
  • Shenzhen Larven Bioengineering Technology Co., Ltd.
  • Shanghai Atom Kexing Pharmaceutical Co., Ltd.
  • Shanghai Xinke Pharmaceutical Co., Ltd.
  • Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
  • Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
  • Guangdong Xi'ai Pharmaceutical Co., Ltd.
  • Chengdu Zhonghe Gaotong Isotope Co., Ltd.
  • Chengdu Yunke Pharmaceutical Co., Ltd.
  • Chengdu Xinke Pharmaceutical Co., Ltd.
  • Beijing Zhibo High-tech Biotechnology Co., Ltd.
  • RadioMedix, Inc.
  • PDRadiopharma Inc.
  • Lantheus
  • Jubilant Radiopharma
  • GE Healthcare Ltd
  • DOE IP

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Radiopharmaceuticals for Diagnosis Sales Value (2021-2032)
  4. 1.2.2 Global Radiopharmaceuticals for Diagnosis Sales Volume (2021-2032)
  5. 1.2.3 Global Radiopharmaceuticals for Diagnosis Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Radiopharmaceuticals for Diagnosis Market Dynamics
  1. 2.1 Radiopharmaceuticals for Diagnosis Industry Trends
  2. 2.2 Radiopharmaceuticals for Diagnosis Industry Drivers
  3. 2.3 Radiopharmaceuticals for Diagnosis Industry Opportunities and Challenges
  4. 2.4 Radiopharmaceuticals for Diagnosis Industry Restraints
3 Radiopharmaceuticals for Diagnosis Market by Company
  1. 3.1 Global Radiopharmaceuticals for Diagnosis Company Revenue Ranking in 2025
  2. 3.2 Global Radiopharmaceuticals for Diagnosis Revenue by Company (2021-2026)
  3. 3.3 Global Radiopharmaceuticals for Diagnosis Sales Volume by Company (2021-2026)
  4. 3.4 Global Radiopharmaceuticals for Diagnosis Average Price by Company (2021-2026)
  5. 3.5 Global Radiopharmaceuticals for Diagnosis Company Ranking (2024-2026)
  6. 3.6 Global Radiopharmaceuticals for Diagnosis Company Manufacturing Base and Headquarters
  7. 3.7 Global Radiopharmaceuticals for Diagnosis Company Product Type and Application
  8. 3.8 Global Radiopharmaceuticals for Diagnosis Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Radiopharmaceuticals for Diagnosis Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Radiopharmaceuticals for Diagnosis Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Radiopharmaceuticals for Diagnosis Market by Type
  1. 4.1 Radiopharmaceuticals for Diagnosis Type Introduction
  2. 4.1.1 Strontium [89Sr] Chloride
  3. 4.1.2 Sodium Iodide [131I]
  4. 4.1.3 Iodine [125I] Sealed Seed Source
  5. 4.1.4 Technetium [99mTc] Pentetate
  6. 4.1.5 Technetium [99mTc] Polymerized Albumin
  7. 4.1.6 Technetium [99mTc] Dithiodithiocarbamate
  8. 4.1.7 Other
  9. 4.2 Global Radiopharmaceuticals for Diagnosis Sales Volume by Type
  10. 4.2.1 Global Radiopharmaceuticals for Diagnosis Sales Volume by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Radiopharmaceuticals for Diagnosis Sales Volume by Type (2021-2032)
  12. 4.2.3 Global Radiopharmaceuticals for Diagnosis Sales Volume Share by Type (2021-2032)
  13. 4.3 Global Radiopharmaceuticals for Diagnosis Sales Value by Type
  14. 4.3.1 Global Radiopharmaceuticals for Diagnosis Sales Value by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Radiopharmaceuticals for Diagnosis Sales Value by Type (2021-2032)
  16. 4.3.3 Global Radiopharmaceuticals for Diagnosis Sales Value Share by Type (2021-2032)
5 Radiopharmaceuticals for Diagnosis Market by Application
  1. 5.1 Radiopharmaceuticals for Diagnosis Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Radiopharmaceuticals for Diagnosis Sales Volume by Application
  6. 5.2.1 Global Radiopharmaceuticals for Diagnosis Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Radiopharmaceuticals for Diagnosis Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Radiopharmaceuticals for Diagnosis Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Radiopharmaceuticals for Diagnosis Sales Value by Application
  10. 5.3.1 Global Radiopharmaceuticals for Diagnosis Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Radiopharmaceuticals for Diagnosis Sales Value by Application (2021-2032)
  12. 5.3.3 Global Radiopharmaceuticals for Diagnosis Sales Value Share by Application (2021-2032)
6 Radiopharmaceuticals for Diagnosis Regional Sales and Value Analysis
  1. 6.1 Global Radiopharmaceuticals for Diagnosis Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Radiopharmaceuticals for Diagnosis Sales by Region (2021-2032)
  3. 6.2.1 Global Radiopharmaceuticals for Diagnosis Sales by Region: 2021-2026
  4. 6.2.2 Global Radiopharmaceuticals for Diagnosis Sales by Region (2027-2032)
  5. 6.3 Global Radiopharmaceuticals for Diagnosis Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Radiopharmaceuticals for Diagnosis Sales Value by Region (2021-2032)
  7. 6.4.1 Global Radiopharmaceuticals for Diagnosis Sales Value by Region: 2021-2026
  8. 6.4.2 Global Radiopharmaceuticals for Diagnosis Sales Value by Region (2027-2032)
  9. 6.5 Global Radiopharmaceuticals for Diagnosis Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Radiopharmaceuticals for Diagnosis Sales Value (2021-2032)
  12. 6.6.2 North America Radiopharmaceuticals for Diagnosis Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Radiopharmaceuticals for Diagnosis Sales Value (2021-2032)
  15. 6.7.2 Europe Radiopharmaceuticals for Diagnosis Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Radiopharmaceuticals for Diagnosis Sales Value (2021-2032)
  21. 6.9.2 South America Radiopharmaceuticals for Diagnosis Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Value Share by Country, 2025 VS 2032
7 Radiopharmaceuticals for Diagnosis Country-level Sales and Value Analysis
  1. 7.1 Global Radiopharmaceuticals for Diagnosis Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Radiopharmaceuticals for Diagnosis Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Radiopharmaceuticals for Diagnosis Sales by Country (2021-2032)
  4. 7.3.1 Global Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026)
  5. 7.3.2 Global Radiopharmaceuticals for Diagnosis Sales by Country (2027-2032)
  6. 7.4 Global Radiopharmaceuticals for Diagnosis Sales Value by Country (2021-2032)
  7. 7.4.1 Global Radiopharmaceuticals for Diagnosis Sales Value by Country (2021-2026)
  8. 7.4.2 Global Radiopharmaceuticals for Diagnosis Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Radiopharmaceuticals for Diagnosis Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Radiopharmaceuticals for Diagnosis Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Radiopharmaceuticals for Diagnosis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Atom High-tech Co., Ltd.
  2. 8.1.1 Atom High-tech Co., Ltd. Company Information
  3. 8.1.2 Atom High-tech Co., Ltd. Business Overview
  4. 8.1.3 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  6. 8.1.5 Atom High-tech Co., Ltd. Recent Developments
  7. 8.2 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
  8. 8.2.1 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Company Information
  9. 8.2.2 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Business Overview
  10. 8.2.3 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Portfolio
  12. 8.2.5 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Recent Developments
  13. 8.3 Tianjin Said Biopharmaceutical Co., Ltd.
  14. 8.3.1 Tianjin Said Biopharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Tianjin Said Biopharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  18. 8.3.5 Tianjin Said Biopharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Shenzhen Larven Bioengineering Technology Co., Ltd.
  20. 8.4.1 Shenzhen Larven Bioengineering Technology Co., Ltd. Company Information
  21. 8.4.2 Shenzhen Larven Bioengineering Technology Co., Ltd. Business Overview
  22. 8.4.3 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  24. 8.4.5 Shenzhen Larven Bioengineering Technology Co., Ltd. Recent Developments
  25. 8.5 Shanghai Atom Kexing Pharmaceutical Co., Ltd.
  26. 8.5.1 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  30. 8.5.5 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Shanghai Xinke Pharmaceutical Co., Ltd.
  32. 8.6.1 Shanghai Xinke Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Shanghai Xinke Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  36. 8.6.5 Shanghai Xinke Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
  38. 8.7.1 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Company Information
  39. 8.7.2 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Business Overview
  40. 8.7.3 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  42. 8.7.5 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Recent Developments
  43. 8.8 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
  44. 8.8.1 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  48. 8.8.5 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Guangdong Xi'ai Pharmaceutical Co., Ltd.
  50. 8.9.1 Guangdong Xi'ai Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Guangdong Xi'ai Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  54. 8.9.5 Guangdong Xi'ai Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Chengdu Zhonghe Gaotong Isotope Co., Ltd.
  56. 8.10.1 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Company Information
  57. 8.10.2 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Business Overview
  58. 8.10.3 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  60. 8.10.5 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Recent Developments
  61. 8.11 Chengdu Yunke Pharmaceutical Co., Ltd.
  62. 8.11.1 Chengdu Yunke Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Chengdu Yunke Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  66. 8.11.5 Chengdu Yunke Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Chengdu Xinke Pharmaceutical Co., Ltd.
  68. 8.12.1 Chengdu Xinke Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Chengdu Xinke Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  72. 8.12.5 Chengdu Xinke Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Beijing Zhibo High-tech Biotechnology Co., Ltd.
  74. 8.13.1 Beijing Zhibo High-tech Biotechnology Co., Ltd. Company Information
  75. 8.13.2 Beijing Zhibo High-tech Biotechnology Co., Ltd. Business Overview
  76. 8.13.3 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  78. 8.13.5 Beijing Zhibo High-tech Biotechnology Co., Ltd. Recent Developments
  79. 8.14 RadioMedix, Inc.
  80. 8.14.1 RadioMedix, Inc. Company Information
  81. 8.14.2 RadioMedix, Inc. Business Overview
  82. 8.14.3 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product Portfolio
  84. 8.14.5 RadioMedix, Inc. Recent Developments
  85. 8.15 PDRadiopharma Inc.
  86. 8.15.1 PDRadiopharma Inc. Company Information
  87. 8.15.2 PDRadiopharma Inc. Business Overview
  88. 8.15.3 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Portfolio
  90. 8.15.5 PDRadiopharma Inc. Recent Developments
  91. 8.16 Lantheus
  92. 8.16.1 Lantheus Company Information
  93. 8.16.2 Lantheus Business Overview
  94. 8.16.3 Lantheus Radiopharmaceuticals for Diagnosis Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Lantheus Radiopharmaceuticals for Diagnosis Product Portfolio
  96. 8.16.5 Lantheus Recent Developments
  97. 8.17 Jubilant Radiopharma
  98. 8.17.1 Jubilant Radiopharma Company Information
  99. 8.17.2 Jubilant Radiopharma Business Overview
  100. 8.17.3 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Portfolio
  102. 8.17.5 Jubilant Radiopharma Recent Developments
  103. 8.18 GE Healthcare Ltd
  104. 8.18.1 GE Healthcare Ltd Company Information
  105. 8.18.2 GE Healthcare Ltd Business Overview
  106. 8.18.3 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Portfolio
  108. 8.18.5 GE Healthcare Ltd Recent Developments
  109. 8.19 DOE IP
  110. 8.19.1 DOE IP Company Information
  111. 8.19.2 DOE IP Business Overview
  112. 8.19.3 DOE IP Radiopharmaceuticals for Diagnosis Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 DOE IP Radiopharmaceuticals for Diagnosis Product Portfolio
  114. 8.19.5 DOE IP Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Radiopharmaceuticals for Diagnosis Value Chain Analysis
  2. 9.1.1 Radiopharmaceuticals for Diagnosis Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Radiopharmaceuticals for Diagnosis Sales Mode & Process
  6. 9.2 Radiopharmaceuticals for Diagnosis Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Radiopharmaceuticals for Diagnosis Distributors
  9. 9.2.3 Radiopharmaceuticals for Diagnosis Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst